Community recruitment of underrepresented populations to the AHEAD 3-45 preclinical AD trial using novel partnerships with nursing and community-based organizations: Lessons and outcomes,Alzheimer's & Dementia

当前位置： X-MOL 学术 › Alzheimers Dement. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Community recruitment of underrepresented populations to the AHEAD 3-45 preclinical AD trial using novel partnerships with nursing and community-based organizations: Lessons and outcomes
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2024-08-29 , DOI: 10.1002/alz.14211
Christian R Salazar ₁ , Melanie Tallakson ₁ , Maria G Corona ₁ , Edwin Duran ₁ , Eunji Russ ₁ , Dan Hoang ₁ , Romina A Romero ₁ , David L Sultzer _{1,

2} , Joshua D Grill _{1,

2,

3} , Hye-Won Shin ₁

Affiliation

Alzheimer's disease (AD) disproportionately affects minoritized populations who remain underrepresented in AD trials.

中文翻译：